Novosorb BTM is to be compared with PolyMedic’s SupraSDRM in a head to head clinical trial.
The 24 patient, randomized, controlled, multi-centre clinical study will compare SupraSDRM to “the standard of care wound dressing, BTM” in the treatment of full-thickness wounds deemed not immediately suitable for definitive grafting.
The study’s primary endpoint is the number of days from application of the dermal substitute until its suitability for grafting but the study will also assess outcomes such as rate of infection, graft survival, return visits to OR, contraction and scarring, pain and overall cost effectiveness.
The trial is expected to commence in September and take approximately 12 months to complete.
The trial is sponsored by the NFP, The Metis Foundation, which is dedicated to advancing US military medical research.
https://ichgcp.net/clinical-trials-registry/NCT06503406
https://metisfoundationusa.org/why-metis/
https://metisfoundationusa.org/dod-researcher-resources/how-we-work-with-military-investigators/
https://metisfoundationusa.org/research-programs/qscarr/
Novosorb BTM is to be compared with PolyMedic’s SupraSDRM in a...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.070(2.70%) |
Mkt cap ! $1.740B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.47 | $3.489M | 1.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3841 | $2.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.54 | 9238 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |